Clincosm LogoSign in Get a demo

Primary Myelofibrosis

Showing 1 - 25 of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy

Recruiting
  • Primary Myelofibrosis
  • 68Ga FAPI PET/CT
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

Not yet recruiting
  • AML
  • +5 more
  • Infusion of CD34 selected hematopoietic stem cells
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 14, 2023

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
May 22, 2023

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Thrombocythemia, Essential, Primary Myelofibrosis Trial in Worldwide (Bomedemstat)

    Enrolling by invitation
    • Thrombocythemia, Essential
    • Primary Myelofibrosis
    • Miami, Florida
    • +18 more
    Jan 30, 2023

    Primary Myelofibrosis Trial in Japan (Fedratinib)

    Recruiting
    • Primary Myelofibrosis
    • Suwa, Nagano, Japan
    • +25 more
    Jan 18, 2023

    Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +13 more
    Jan 10, 2023

    Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

    Active, not recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +11 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 10, 2023

    Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

    Active, not recruiting
    • Acute Leukemia
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

    Recruiting
    • Myelofibrosis; Anemia
    • +5 more
    • Jacksonville, Florida
    • +6 more
    Jan 3, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Berkeley, California
    • +176 more
    Dec 1, 2022

    Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

    Recruiting
    • Myelofibrosis
    • +3 more
    • Anchorage, Alaska
    • +172 more
    Dec 1, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Worcester, Massachusetts
    • +16 more
    Oct 31, 2022

    Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +148 more
    Oct 10, 2022

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Birmingham, Alabama
    • +151 more
    Aug 22, 2022

    Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

    Recruiting
    • Myeloproliferative Disorders
    • +4 more
    • La Jolla, California
    • +184 more
    Aug 22, 2022

    Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022

    Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)

    Completed
    • Primary Myelofibrosis
    • Anemia
    • Phoenix, Arizona
    • +24 more
    Aug 17, 2022

    Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

    Terminated
    • Essential Thrombocythemia
    • +2 more
    • Arsenic Trioxide
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)

    Recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +9 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jun 21, 2022

    Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)

    Recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Greifswald, Germany
    • +1 more
    Jun 15, 2022